← Back to Search

Behavioral Intervention

Academic Detailing + LEAP for Suicide Prevention (MIDAS SPCT Trial)

N/A
Waitlist Available
Led By Jeremy B. Sussman, MD MS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12-months post-baseline
Awards & highlights

MIDAS SPCT Trial Summary

This trial focuses on improving suicide prevention treatment for Veterans by increasing referrals to the SP 2.0 initiative through Academic Detailing and LEAP.

Who is the study for?
This trial is for VA medical centers aiming to improve suicide prevention. Centers should have data access, necessary resources, a team leader or champion, and departmental leadership support. It's not for individual patients but clinics ready to optimize evidence-based practices.Check my eligibility
What is being tested?
The MIDAS program is testing the effectiveness of Academic Detailing (AD) and LEAP in increasing referrals to Suicide Prevention 2.0 Clinical Telehealth (SP 2.0), which offers telehealth treatment for suicidal Veterans.See study design
What are the potential side effects?
Since this trial involves implementation strategies rather than direct patient interventions, traditional side effects are not applicable. However, there may be indirect impacts on clinic workflow or provider practices.

MIDAS SPCT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12-months post-baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12-months post-baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Referral to SP 2.0 Clinic
Secondary outcome measures
Completion of Cognitive Behavioral Therapy for Suicide Prevention at SP 2.0 clinic
Completion of Dialectical Behavior Therapy
Completion of Problem Solving Therapy for Suicide Prevention
+3 more
Other outcome measures
Change in Best Places to Work Score
Change in Employee Burnout
Change in Employee Engagement in Quality Improvement
+4 more

MIDAS SPCT Trial Design

2Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment2 Interventions
A multi-faceted implementation intervention including qualitative interviews and feedback and optional delivery of Academic Detailing and/or LEAP.
Group II: ControlExperimental Treatment1 Intervention
Control sites will be selected to match intervention sites on baseline referral rates.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LEAP
2016
N/A
~74250
Usual care
2011
Completed Phase 4
~23770

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,449 Total Patients Enrolled
13 Trials studying Suicidal Ideation
2,387 Patients Enrolled for Suicidal Ideation
Jeremy B. Sussman, MD MSPrincipal InvestigatorVA Ann Arbor Healthcare System, Ann Arbor, MI
2 Previous Clinical Trials
67 Total Patients Enrolled
Paul N Pfeiffer, MD MSPrincipal InvestigatorVA Ann Arbor Healthcare System, Ann Arbor, MI
3 Previous Clinical Trials
560 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for this experiment still available?

"As per the clinicaltrials.gov website, this particular medical study is no longer enrolling patients. Originally posted on November 1st 2022 and most recent updated on August 24th 2023, it has finished recruiting candidates; however, there are still 188 other trials that are currently looking for participants."

Answered by AI
~1 spots leftby Oct 2024